GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform ...

We conducted a randomised trial comparing tissue acquisition between the 22-gauge (G) Franseen biopsy (Acquire, Boston Scientific) and 22G standard bevel FNA (Expect, Boston Scientific) ...

(UroToday.com) The Interdisciplinary Genitourinary Cancer Forum 2025, held in St. Petersburg, Florida, United States, was host to the Prostate Cancer Session 2: Local Treatments. Dr. Peter Carroll ...

My mother has been diagnosed with breast cancer, and I’m helping with her medical appointments. Her oncologist says she needs a liquid biopsy. She has already had a ...

The global breast biopsy market is anticipated to grow at a steady CAGR of 5.5% during the forecast period 2020-2026, according to a report by Gen Consulting Company.

The global Breast Biopsy Devices Market is projected to be valued at USD 2.47 billion in 2025 and is expected to reach USD 4.21 billion by 2035, registering a CAGR of 5.5% during the forecast period.

A new PET/CT imaging technique that visualizes activated fibroblasts in the heart muscle enables early detection of multiple forms of cardiomyopathy, according to research presented at the Society of ...

AI model crossNN identifies over 170 tumor types with high accuracy using genetic material, offering fast, non-invasive ...

Major inclusion criteria included age ≥18 years, histopathologic diagnosis of NSCLC on a tissue biopsy performed within 90 days of enrollment, documented EGFR mutation as described above, staging ...

GeneCentric Therapeutics has earned an initial $8m in a Series C funding round, marking a step towards the launch and ...

A biopsy of metastatic sites costs around $16,000, and while Angle hasn’t divulged its pricing plans for Parsortix' clinical applications for research purposes the single-use test costs around $100.